Clinical trials
Terminated Observational trials in the Netherlands
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
129 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2004 | 1 |
| 2005 | 4 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 5 |
| 2009 | 2 |
| 2010 | 7 |
| 2011 | 6 |
| 2012 | 10 |
| 2013 | 6 |
| 2014 | 7 |
| 2015 | 10 |
| 2016 | 10 |
| 2017 | 8 |
| 2018 | 7 |
| 2019 | 12 |
| 2020 | 7 |
| 2021 | 8 |
| 2022 | 7 |
| 2023 | 5 |
| 2024 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 129 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Radboud University Medical Center | 16 |
| Maastricht University Medical Center | 9 |
| Abbott Medical Devices | 5 |
| Amsterdam UMC, location VUmc | 5 |
| AstraZeneca | 4 |
| Leiden University Medical Center | 4 |
| UMC Utrecht | 4 |
| Maastricht Radiation Oncology | 3 |
| University Medical Center Groningen | 3 |
| Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Aortic Aneurysm, Abdominal | 4 |
| Breast Neoplasms | 4 |
| Myocardial Infarction | 4 |
| COVID-19 | 3 |
| Diabetes Mellitus, Type 2 | 3 |
| Heart Failure | 3 |
| Neoplasms | 3 |
| Recurrence | 3 |
| Shock | 3 |
| Adrenal Insufficiency | 2 |
Trials
Showing 1 to 25 of 129. Each trial links to its page on Pharma Observatory.
29 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.